Rhythm Pharmaceuticals buy Canaccord Genuity Group Inc.
Start price
02.03.23
/
50%
€21.20
Target price
02.03.24
€52.93
Performance (%)
85.85%
End price
03.03.24
€39.40
Summary
This prediction ended on 03.03.24 with a price of €39.40. The BUY prediction by Canaccord_Genuity_Gr for Rhythm Pharmaceuticals saw massive gains of 85.85%. Canaccord_Genuity_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Rhythm Pharmaceuticals | - | - | - |
| iShares Core DAX® | -1.114% | 3.430% | 25.966% |
| iShares Nasdaq 100 | 1.816% | 6.911% | 30.390% |
| iShares Nikkei 225® | 2.113% | 5.501% | 23.404% |
| iShares S&P 500 | 2.038% | 5.327% | 30.881% |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) had its price target raised by analysts at Canaccord Genuity Group Inc. from $52.00 to $56.00. They now have a "buy" rating on the stock.
Ratings data for RYTM provided by MarketBeat
In the thread Trading Rhythm Pharmaceuticals
Die von Canaccord_Genuity_Gr gewählte maximale Laufzeit wurde überschritten